Literature DB >> 31571168

Roles of Hepatic Drug Transporters in Drug Disposition and Liver Toxicity.

Guoyu Pan1.   

Abstract

Hepatic drug transporters are mainly distributed in parenchymal liver cells (hepatocytes), contributing to drug's liver disposition and elimination. According to their functions, hepatic transporters can be roughly divided into influx and efflux transporters, translocating specific molecules from blood into hepatic cytosol and mediating the excretion of drugs and metabolites from hepatic cytosol to blood or bile, respectively. The function of hepatic transport systems can be affected by interspecies differences and inter-individual variability (polymorphism). In addition, some drugs and disease can redistribute transporters from the cell surface to the intracellular compartments, leading to the changes in the expression and function of transporters. Hepatic drug transporters have been associated with the hepatic toxicity of drugs. Gene polymorphism of transporters and altered transporter expressions and functions due to diseases are found to be susceptible factors for drug-induced liver injury (DILI). In this chapter, the localization of hepatic drug transporters, their regulatory factors, physiological roles, and their roles in drug's liver disposition and DILI are reviewed.

Entities:  

Keywords:  DILI; Drug disposition; Hepatic drug transporters; Hepatotoxicity

Mesh:

Substances:

Year:  2019        PMID: 31571168     DOI: 10.1007/978-981-13-7647-4_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  10 in total

Review 1.  Comparison of Canine and Human Physiological Factors: Understanding Interspecies Differences that Impact Drug Pharmacokinetics.

Authors:  Marilyn N Martinez; Jonathan P Mochel; Sibylle Neuhoff; Devendra Pade
Journal:  AAPS J       Date:  2021-04-27       Impact factor: 4.009

2.  In silico approaches in organ toxicity hazard assessment: current status and future needs in predicting liver toxicity.

Authors:  Arianna Bassan; Vinicius M Alves; Alexander Amberg; Lennart T Anger; Scott Auerbach; Lisa Beilke; Andreas Bender; Mark T D Cronin; Kevin P Cross; Jui-Hua Hsieh; Nigel Greene; Raymond Kemper; Marlene T Kim; Moiz Mumtaz; Tobias Noeske; Manuela Pavan; Julia Pletz; Daniel P Russo; Yogesh Sabnis; Markus Schaefer; David T Szabo; Jean-Pierre Valentin; Joerg Wichard; Dominic Williams; David Woolley; Craig Zwickl; Glenn J Myatt
Journal:  Comput Toxicol       Date:  2021-09-09

Review 3.  Contribution of Humanized Liver Chimeric Mice to the Study of Human Hepatic Drug Transporters: State of the Art and Perspectives.

Authors:  Anna Zerdoug; Marc Le Vée; Shotaro Uehara; Béatrice Lopez; Christophe Chesné; Hiroshi Suemizu; Olivier Fardel
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2022-07-06       Impact factor: 2.569

4.  Pharmacokinetic and toxicodynamic concepts in idiosyncratic, drug-induced liver injury.

Authors:  Robert A Roth; Omar Kana; David Filipovic; Patricia E Ganey
Journal:  Expert Opin Drug Metab Toxicol       Date:  2022-08-24       Impact factor: 4.936

5.  Sex-, Age-, and Race/Ethnicity-Dependent Variations in Drug-Processing and NRF2-Regulated Genes in Human Livers.

Authors:  Jie Liu; Julia Yue Cui; Yuan-Fu Lu; J Christopher Corton; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2020-11-08       Impact factor: 3.922

Review 6.  Human biomimetic liver microphysiology systems in drug development and precision medicine.

Authors:  Albert Gough; Alejandro Soto-Gutierrez; Lawrence Vernetti; Mo R Ebrahimkhani; Andrew M Stern; D Lansing Taylor
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-12-17       Impact factor: 73.082

7.  Study of Endogen Substrates, Drug Substrates and Inhibitors Binding Conformations on MRP4 and Its Variants by Molecular Docking and Molecular Dynamics.

Authors:  Edgardo Becerra; Giovanny Aguilera-Durán; Laura Berumen; Antonio Romo-Mancillas; Guadalupe García-Alcocer
Journal:  Molecules       Date:  2021-02-17       Impact factor: 4.411

8.  Natural Phaeosphaeride A Derivatives Overcome Drug Resistance of Tumor Cells and Modulate Signaling Pathways.

Authors:  Victoria Abzianidze; Natalia Moiseeva; Diana Suponina; Sofya Zakharenkova; Nadezhda Rogovskaya; Lidia Laletina; Alvin A Holder; Denis Krivorotov; Alexander Bogachenkov; Alexander Garabadzhiu; Anton Ukolov; Vyacheslav Kosorukov
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-24

9.  PPARα-Dependent Modulation by Metformin of the Expression of OCT-2 and MATE-1 in the Kidney of Mice.

Authors:  Adriano Cleis Arruda; Mauro Sérgio Perilhão; Warley Almeida Santos; Marcos Fernandes Gregnani; Alexandre Budu; José Cesar Rosa Neto; Gabriel Rufino Estrela; Ronaldo Carvalho Araujo
Journal:  Molecules       Date:  2020-01-17       Impact factor: 4.411

Review 10.  Drug-Drug Interactions in Vestibular Diseases, Clinical Problems, and Medico-Legal Implications.

Authors:  Giulio Di Mizio; Gianmarco Marcianò; Caterina Palleria; Lucia Muraca; Vincenzo Rania; Roberta Roberti; Giuseppe Spaziano; Amalia Piscopo; Valeria Ciconte; Nunzio Di Nunno; Massimiliano Esposito; Pasquale Viola; Davide Pisani; Giovambattista De Sarro; Milena Raffi; Alessandro Piras; Giuseppe Chiarella; Luca Gallelli
Journal:  Int J Environ Res Public Health       Date:  2021-12-08       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.